Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years~* Granulomatosis with polyangiitis or microscopic polyangiitis (according to Chapel Hill criterions), with or without detectable ANCA~* Decision taken to start an induction regimen with rituximab~* Informed and having signed the study consent form~* If of child-bearing potential, female patients will have use an effective method of contraception during RTX (rituximab) treatment and in the 12 months following RTX treatment stop~* no-breast-feeding during RTX treatment and in the 12 months following RTX treatment stop~Exclusion Criteria:~* Other primary or secondary systemic vasculitis~* Incapacity or refusal to sign the informed consent form~* Incapacity or refusal to adhere to treatment or perform the follow-up examinations required by the study~* Allergy, documented hypersensitivity or contraindication to the medications used in the present study (corticosteroids, rituximab)~* severe active infection~* Patient with severe heart failure (stage NYHA IV) or any other unstable heart disease Pregnancy, except for cases where the expected benefit oj treatment seems to surpass the potential risks~* Patients with active hepatitis B~* Any live vaccine within four weeks prior to the first infusion of RTX

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Rituximab (Type: None): a classical induction regimen with rituximab (decision taken before inclusion), implying an infusion of 375mg/m² per week, for 4 consecutive weeks (from week -3 until week 0) with blood specimen.

Based on this trial design, predict the completion outcome and termination type (if applicable).